Swiss National Bank
PETX

Swiss National Bank’s Aratana Therapeutics, Inc. PETX Stock Holding History

Swiss National Bank’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-41,300
Closed -$349K – 2671
2015
Q3 		$349K Buy
41,300
+4,900
+13% +$82.9K ﹤0.01% 2346
2015
Q2 		$550K Hold
36,400
– – ﹤0.01% 2185
2015
Q1 		$583K Hold
36,400
– – ﹤0.01% 2092
2014
Q4 		$649K Hold
36,400
– – ﹤0.01% 2006
2014
Q3 		$365K Buy
36,400
+21,000
+136% +$255K ﹤0.01% 2266
2014
Q2 		$240K Hold
15,400
– – ﹤0.01% 2439
2014
Q1 		$286K Buy
15,400
+12,100
+367% +$242K ﹤0.01% 2338
2013
Q4 		$63K Buy
+3,300
New +$67K ﹤0.01% 2503

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Swiss National Bank's PETX Position: Q4 2015 in Review

Swiss National Bank sold out of Aratana Therapeutics, Inc. (PETX) in Q4 2015, closing a stake of 41,300 shares — an estimated $349K sold.

Swiss National Bank first reported a position in PETX in Q4 2013 and held it in 8 quarters. The position peaked at $649K in Q4 2014. 98 funds tracked by Wall St. Rank hold PETX as of Q4 2015.

  • Swiss National Bank reported no remaining Aratana Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
  • Swiss National Bank sold 41,300 Aratana Therapeutics, Inc. shares in Q4 2015, an estimated $349K.
  • Swiss National Bank first reported a position in Aratana Therapeutics, Inc. in Q4 2013 and held it in 8 quarters.
  • Swiss National Bank's Aratana Therapeutics, Inc. position peaked at $649K in Q4 2014.
  • 98 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2015.

Based on Swiss National Bank's 13F filing for Q4 2015, filed 3 Feb 2016.